Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 257 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named HR 1262. Clear
Clear
Q1
CYSTIC FIBROSIS FOUNDATION for CYSTIC FIBROSIS FOUNDATION
1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate
Health Issues, Insurance, Budget/Appropriations, Medical/Disease Research/Clinical Labs
View →
Q1
BIOMARIN PHARMACEUTICAL INC. for BIOMARIN PHARMACEUTICAL INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Taxation/Internal Revenue Code
View →
Q1
ALLIANCE FOR REGENERATIVE MEDICINE for ALLIANCE FOR REGENERATIVE MEDICINE
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q1
BAYER CORPORATION (CONSOLIDATED REPORT) for BAYER CORPORATION (CONSOLIDATED REPORT)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Medicare/Medicaid, Tariff (miscellaneous tariff bills), Budget/Appropriations
View →
Q1
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
INCYTE CORPORATION for INCYTE CORPORATION
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate
Medicare/Medicaid
View →
Q1
COVINGTON & BURLING LLP for PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · $420,000.00 income
Copyright/Patent/Trademark, Health Issues
View →
Q1
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Agriculture, Animals, Budget/Appropriations, Chemicals/Chemical Industry
View →
1A
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Medicare/Medicaid, Pharmacy, Science/Technology
View →
Q1
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Manufacturing, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q1
ASTRAZENECA PHARMACEUTICALS LP for ASTRAZENECA PHARMACEUTICALS LP
1st Quarter (Jan 1 - Mar 31) 2025 · Delaware · House · Senate
Health Issues, Medicare/Medicaid, Pharmacy, Taxation/Internal Revenue Code
View →
Q1
AVENUE SOLUTIONS for ALLIANCE FOR REGENERATIVE MEDICINE
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · Senate · $50,000.00 income
Medicare/Medicaid
View →
Q1
THE KPM GROUP DC LLC for SOLENO THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $50,000.00 income
Health Issues
View →
Q1
THE KPM GROUP DC LLC for PRAXIS PRECISION MEDICINES
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
THE KPM GROUP DC LLC for ASTRIA THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income
Pharmacy
View →
Q1
PTC THERAPEUTICS, INC. for PTC THERAPEUTICS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Taxation/Internal Revenue Code
View →
Q1
NOVARTIS for NOVARTIS
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q1
AKIN GUMP STRAUSS HAUER & FELD for BIOTECHNOLOGY INNOVATION ORGANIZATION
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Health Issues
View →
Q1
EVERYLIFE FOUNDATION FOR RARE DISEASES for EVERYLIFE FOUNDATION FOR RARE DISEASES
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues
View →
Q1
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK, INC. for AMERICAN CANCER SOCIETY CANCER ACTION NETWORK INC
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate
Health Issues, Taxation/Internal Revenue Code, Tobacco, Budget/Appropriations
View →
Q1
ROBERTI GLOBAL (FKA ROBERTI WHITE, LLC) for BIOTECHNOLOGY INNOVATION ORGANIZATION (BIO)
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues
View →
Q1
TIBER CREEK GROUP for ACADIA PHARMACEUTICALS, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $80,000.00 income
Health Issues, Taxation/Internal Revenue Code
View →
Q1
ORCHARD THERAPEUTICS NORTH AMERICA for ORCHARD THERAPEUTICS NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate
Health Issues, Medicare/Medicaid
View →
Q1
LMH STRATEGIC SOLUTIONS for STEALTH BIOTHERAPEUTICS INC.
1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $10,000.00 income
Health Issues
View →
Q1
BRIDGEBIO PHARMA, INC. for BRIDGEBIO PHARMA, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate
Pharmacy
View →
Previous Page 10 of 11 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem